A detailed history of Deutsche Bank Ag\ transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 6,203 shares of MCRB stock, worth $4,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,203
Previous 6,203 -0.0%
Holding current value
$4,466
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.93 - $2.15 $45,407 - $104,973
-48,825 Reduced 88.73%
6,203 $8,000
Q3 2023

Nov 09, 2023

BUY
$2.33 - $5.07 $15,324 - $33,345
6,577 Added 13.57%
55,028 $130,000
Q2 2023

Aug 14, 2023

SELL
$4.67 - $6.55 $59,598 - $83,591
-12,762 Reduced 20.85%
48,451 $232,000
Q1 2023

May 15, 2023

BUY
$4.95 - $6.09 $67,958 - $83,609
13,729 Added 28.91%
61,213 $347,000
Q4 2022

Feb 13, 2023

BUY
$5.09 - $9.05 $81,475 - $144,863
16,007 Added 50.85%
47,484 $265,000
Q3 2022

Nov 14, 2022

SELL
$3.5 - $7.2 $29,879 - $61,466
-8,537 Reduced 21.34%
31,477 $202,000
Q2 2022

Aug 11, 2022

SELL
$2.7 - $7.62 $43,591 - $123,024
-16,145 Reduced 28.75%
40,014 $137,000
Q1 2022

May 13, 2022

SELL
$6.3 - $8.84 $1.41 Million - $1.98 Million
-223,820 Reduced 79.94%
56,159 $399,000
Q4 2021

Feb 11, 2022

BUY
$6.02 - $11.43 $1.21 Million - $2.3 Million
201,437 Added 256.47%
279,979 $2.33 Million
Q3 2021

Nov 04, 2021

BUY
$5.46 - $22.6 $172,404 - $713,617
31,576 Added 67.23%
78,542 $547,000
Q2 2021

Aug 11, 2021

SELL
$18.46 - $24.36 $294,400 - $388,493
-15,948 Reduced 25.35%
46,966 $1.12 Million
Q1 2021

May 13, 2021

BUY
$17.66 - $28.92 $305,906 - $500,952
17,322 Added 37.99%
62,914 $1.3 Million
Q4 2020

Feb 16, 2021

BUY
$23.25 - $37.73 $386,856 - $627,789
16,639 Added 57.47%
45,592 $1.12 Million
Q3 2020

Nov 12, 2020

BUY
$3.74 - $28.74 $20,887 - $160,512
5,585 Added 23.9%
28,953 $820,000
Q2 2020

Aug 13, 2020

BUY
$3.04 - $6.2 $33,339 - $67,995
10,967 Added 88.44%
23,368 $111,000
Q1 2020

May 14, 2020

SELL
$2.64 - $3.82 $1,958 - $2,834
-742 Reduced 5.65%
12,401 $45,000
Q4 2019

Feb 14, 2020

BUY
$2.99 - $4.42 $8,733 - $12,910
2,921 Added 28.58%
13,143 $44,000
Q3 2019

Nov 14, 2019

SELL
$2.29 - $4.16 $10,932 - $19,859
-4,774 Reduced 31.84%
10,222 $40,000
Q2 2019

Aug 14, 2019

SELL
$2.28 - $7.35 $19,131 - $61,673
-8,391 Reduced 35.88%
14,996 $46,000
Q1 2019

May 15, 2019

BUY
$4.83 - $7.21 $2,999 - $4,477
621 Added 2.73%
23,387 $159,000
Q4 2018

Feb 14, 2019

SELL
$4.52 - $8.88 $132,973 - $261,240
-29,419 Reduced 56.37%
22,766 $102,000
Q3 2018

Dec 21, 2021

BUY
$7.33 - $9.23 $82,645 - $104,068
11,275 Added 27.56%
52,185 $396,000
Q3 2018

Nov 14, 2018

SELL
$7.33 - $9.23 $76,107 - $95,835
-10,383 Reduced 20.24%
40,910 $309,000
Q2 2018

Apr 21, 2020

BUY
$6.91 - $9.55 $88,945 - $122,927
12,872 Added 33.5%
51,293 $441,000
Q2 2018

Aug 14, 2018

SELL
$6.91 - $9.55 $948,369 - $1.31 Million
-137,246 Reduced 78.13%
38,421 $330,000
Q1 2018

Oct 18, 2019

BUY
$7.34 - $11.16 $94,465 - $143,629
12,870 Added 7.91%
175,667 $1.29 Million
Q1 2018

May 15, 2018

SELL
$7.34 - $11.16 $472,644 - $718,625
-64,393 Reduced 28.34%
162,797 $1.19 Million
Q4 2017

Feb 14, 2018

BUY
$9.15 - $12.64 $1.23 Million - $1.7 Million
134,874 Added 146.1%
227,190 $2.3 Million
Q3 2017

Nov 14, 2017

BUY
$12.81 - $16.85 $1.18 Million - $1.56 Million
92,316
92,316 $1.48 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.